• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺滤泡癌的死亡

The demise of follicular carcinoma of the thyroid gland.

作者信息

LiVolsi V A, Asa S L

机构信息

Department of Pathology, University of Pennsylvania, Philadelphia.

出版信息

Thyroid. 1994 Summer;4(2):233-6. doi: 10.1089/thy.1994.4.233.

DOI:10.1089/thy.1994.4.233
PMID:7920009
Abstract

Over the past several decades, iodide supplementation to food supplies in many parts of the world has been followed by a corresponding decrease in the incidence of follicular thyroid carcinoma. However, pathologists continue to over-diagnose this tumor. Benign lesions (e.g., partly encapsulated hyperplastic nodules, pseudoinvasion after fine needle aspiration), and malignancies (especially the follicular variant of papillary carcinoma) have been misinterpreted as follicular carcinoma. Since the clinical features and biological behavior of true follicular cancer differ from the entities with which it may be confused, it is essential that appropriate histological criteria be applied to the diagnostic interpretation of thyroid nodules that exhibit follicular architecture. Only in this way will it be possible to define prognosis and to evaluate treatment options.

摘要

在过去几十年里,世界上许多地区在食物供应中添加碘之后,滤泡性甲状腺癌的发病率相应下降。然而,病理学家仍在过度诊断这种肿瘤。良性病变(如部分包膜化的增生性结节、细针穿刺后的假浸润)以及恶性肿瘤(尤其是乳头状癌的滤泡变体)都被误诊为滤泡性癌。由于真正的滤泡性癌的临床特征和生物学行为与可能与之混淆的病变不同,因此必须将适当的组织学标准应用于对呈现滤泡结构的甲状腺结节的诊断解读。只有这样,才有可能确定预后并评估治疗方案。

相似文献

1
The demise of follicular carcinoma of the thyroid gland.甲状腺滤泡癌的死亡
Thyroid. 1994 Summer;4(2):233-6. doi: 10.1089/thy.1994.4.233.
2
[Problems in the diagnosis of thyroid papillary and follicular carcinoma].[甲状腺乳头状癌和滤泡状癌的诊断问题]
Zhonghua Bing Li Xue Za Zhi. 2007 Apr;36(4):220-3.
3
[The frequency of malignant disease in cytological group of suspected cancer (ultrasound-guided fine-needle aspiration biopsy of nonpalpable thyroid nodules)].[疑似癌症细胞学组(超声引导下不可触及甲状腺结节细针穿刺活检)中恶性疾病的发生率]
Medicina (Kaunas). 2008;44(3):189-94.
4
Combined clinical, thyroid ultrasound and cytological features help to predict thyroid malignancy in follicular and Hupsilonrthle cell thyroid lesions: results from a series of 505 consecutive patients.结合临床、甲状腺超声和细胞学特征有助于预测滤泡性和许特尔细胞甲状腺病变中的甲状腺恶性肿瘤:来自连续505例患者的系列研究结果。
Clin Endocrinol (Oxf). 2007 Jan;66(1):13-20. doi: 10.1111/j.1365-2265.2006.02677.x.
5
[Fine-needle aspiration biopsy of the thyroid nodule: uses and limitations].[甲状腺结节的细针穿刺活检:用途与局限性]
Nihon Rinsho. 2007 Nov;65(11):2003-7.
6
Preoperative diagnosis of the follicular variant of papillary carcinoma of the thyroid: discrepancy between image and cytologic diagnoses.甲状腺乳头状癌滤泡变体的术前诊断:影像诊断与细胞学诊断之间的差异
Radiat Med. 1994 Nov-Dec;12(6):293-9.
7
TROP-2 expression in papillary thyroid carcinoma: Potential Diagnostic Utility.TROP-2在甲状腺乳头状癌中的表达:潜在的诊断效用。
Diagn Cytopathol. 2016 Jan;44(1):26-31. doi: 10.1002/dc.23382. Epub 2015 Oct 19.
8
One in four patients with follicular thyroid cytology (THY3) has a thyroid carcinoma.四分之一的滤泡性甲状腺细胞学检查(THY3)患者患有甲状腺癌。
Thyroid. 2009 Jan;19(1):33-7. doi: 10.1089/thy.2008.0200.
9
Follicular thyroid lesions, elements that affect both diagnosis and prognosis.滤泡性甲状腺病变,这些因素会影响诊断和预后。
J Surg Oncol. 2005 Mar 1;89(3):108-13. doi: 10.1002/jso.20186.
10
Controversies in diagnostic approaches to the indeterminate follicular thyroid nodule.不确定型甲状腺滤泡性结节诊断方法中的争议
Biomed Pharmacother. 2005 Oct;59(9):517-20. doi: 10.1016/j.biopha.2005.04.003. Epub 2005 Aug 11.

引用本文的文献

1
Non-Invasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features (NIFTPs).具有乳头样核特征的非侵袭性滤泡性甲状腺肿瘤(NIFTPs)
Kaohsiung J Med Sci. 2025 Jun;41(6):e70051. doi: 10.1002/kjm2.70051. Epub 2025 May 31.
2
The Asian Thyroid Working Group, from 2017 to 2023.亚洲甲状腺工作组,2017年至2023年。
J Pathol Transl Med. 2023 Nov;57(6):289-304. doi: 10.4132/jptm.2023.10.04. Epub 2023 Nov 14.
3
Pathogenesis of cancers derived from thyroid follicular cells.甲状腺滤泡细胞来源癌的发病机制。
Nat Rev Cancer. 2023 Sep;23(9):631-650. doi: 10.1038/s41568-023-00598-y. Epub 2023 Jul 12.
4
Multi-Omics and Management of Follicular Carcinoma of the Thyroid.甲状腺滤泡癌的多组学与管理
Biomedicines. 2023 Apr 19;11(4):1217. doi: 10.3390/biomedicines11041217.
5
Oncocytic Papillary Thyroid Carcinoma and Oncocytic Poorly Differentiated Thyroid Carcinoma: Clinical Features, Uptake, and Response to Radioactive Iodine Therapy, and Outcome.嗜酸细胞性甲状腺乳头状癌和嗜酸细胞性甲状腺低分化癌:临床特征、摄取、对放射性碘治疗的反应和结局。
Front Endocrinol (Lausanne). 2021 Dec 16;12:795184. doi: 10.3389/fendo.2021.795184. eCollection 2021.
6
The Emerging Landscapes of Long Noncoding RNA in Thyroid Carcinoma: Biological Functions and Clinical Significance.甲状腺癌中长链非编码RNA的新前景:生物学功能及临床意义
Front Oncol. 2021 Aug 10;11:706011. doi: 10.3389/fonc.2021.706011. eCollection 2021.
7
Diagnostic Value of Serum lncRNA HOTAIR Combined with Galectin-3 in Benign and Papillary Thyroid Carcinoma.血清长链非编码RNA HOTAIR联合半乳糖凝集素-3在甲状腺良性及乳头状癌中的诊断价值
Cancer Manag Res. 2021 Aug 19;13:6517-6525. doi: 10.2147/CMAR.S312784. eCollection 2021.
8
The contribution of molecular pathology to the classification of thyroid tumors.分子病理学在甲状腺肿瘤分类中的贡献。
Diagn Histopathol (Oxf). 2018 Mar;24(3):87-94. doi: 10.1016/j.mpdhp.2018.02.001.
9
Molecular Pathology of Non-familial Follicular Epithelial-Derived Thyroid Cancer in Adults: From RAS/BRAF-like Tumor Designations to Molecular Risk Stratification.成人非家族性滤泡上皮来源甲状腺癌的分子病理学:从 RAS/BRAF 样肿瘤分类到分子风险分层。
Endocr Pathol. 2021 Mar;32(1):44-62. doi: 10.1007/s12022-021-09666-1. Epub 2021 Mar 2.
10
Ablation therapy using a low dose of radioiodine may be sufficient in low- to intermediate-risk patients with follicular variant papillary thyroid carcinoma.对于低至中风险的滤泡状变异型甲状腺乳头状癌患者,使用低剂量放射性碘的消融治疗可能就足够了。
J Int Med Res. 2020 Nov;48(11):300060520966491. doi: 10.1177/0300060520966491.